Feasibility, safety and efficacy of laparoscopic sleeve gastrectomy for obese patients with BMI over 32.0 kg/m2: A prospective, non-randomized, single center study - Laparoscopic sleeve gastrectomy for obese patients

Hamamatsu University School of Medicine0 个研究点目标入组 5 人开始时间: 2016年11月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Cardiovascular event in the past 6 months or unstable ungina 2) Pulmonary embolus or thrombophlebitis in the past 6 months 3) Cancer of any kind unless documented to be disease-free for 5 years 4) Significant anemia or coagulopathy 5) Renal dysfunction: serum creatinine 2.0 mg/dl and over 6) Hepatic dysfunction: serum total bilirubin greater than 1.5 times the upper limit of normal, or alkaline phosphatase or ALT greater than twice the upper limit of normal. Chronic hepatitis B or C, cirrhosis 7) History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or colon resection. 8) Gastric or duodenal ulcer in the past 6 months 9) History of intra-abdominal sepsis 10) Currently pregnant or nursing 11) Receiving steroids 12) Receiving immune suppressor 13) Patients with pulmonary disease and require continuous oxygen therapy 14) History of alcohol or drug dependency in the past 5 years 15) Patients with psychiatric or mental disorders 16) Exclusions may also be made at the discretion of the attending physician

发起方